Please select a region
Manage Consent Preferences
Strictly Functional Cookie
Our site is undergoing a scheduled maintenance from 30th December 2020 to 3rd January 2021 and some functionalities will not be available at this time
十月 10, 2019
New FDA Guidance on “Considerations in Demonstrating Interchangeability with a Reference Product” – How West is Working to Support Biosimilar Companies
The development of new biosimilar products has increased over the past several years. Europe and Asia Pacific have been leading the industry with the greatest number of biosimilars being introduced to the market. Given the demand to reduce medical costs for patients, this trend is expected to increase globally in the coming years.
五月 22, 2013